Novo A/S 13D and 13G filings for Checkmate Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-06-03 3:01 pm Sale | 2022-05-31 | 13D | Checkmate Pharmaceuticals, Inc. CMPI | Novo A/S | 0 0.000% | -1,828,484 (Position Closed) | Filing |
| 2022-05-11 2:57 pm Sale | 2022-05-05 | 13D | Checkmate Pharmaceuticals, Inc. CMPI | Novo A/S | 1,828,484 8.300% | -341,616 (-15.74%) | Filing |
| 2021-11-01 4:03 pm Unchanged | 2021-11-01 | 13D | Checkmate Pharmaceuticals, Inc. CMPI | Novo A/S | 2,170,100 10.000% | 0 (Unchanged) | Filing |
| 2020-08-13 4:47 pm Purchase | 2020-08-11 | 13D | Checkmate Pharmaceuticals, Inc. CMPI | Novo A/S | 2,170,100 10.100% | 2,170,100 (New Position) | Filing |